Clinical Trial Results: Gemcitabine, Trastuzumab, and Pertuzumab in the Treatment of Metastatic HER2-Positive Breast Cancer After Prior Trastuzumab/Pertuzumab, or Pertuzumab Based Therapy [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating gemcitabine, trastuzumab, and pertuzumab in metastatic HER2-positive breast cancer after prior anti-HER2 therapy; results completed and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Gemcitabine (Gemcitabine)
• Pertuzumab (pertuzumab)
• Trastuzumab (trastuzumab)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Metastatic HER2-Positive Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2026-07-24